Posted by The prevalence and incidence of obesity and the comorbidities linked to it are increasing worldwide. Current therapies for obesity and associated pathologies have proven to cause a broad number of adverse effects, and often, they are overpriced or not affordable for all patients. Among the alternatives currently available, natural bioactive compounds stand out. These are frequently contained in pharmaceutical presentations, nutraceutical products, supplements, or functional foods. The clinical evidence for these molecules is increasingly solid, among which epigallocatechin-3-gallate, ellagic acid, resveratrol, berberine, anthocyanins, probiotics, carotenoids, curcumin, silymarin, hydroxy citric acid, and α-lipoic acid stand out. The molecular mechanisms and signaling pathways of these molecules have been shown to interact with the endocrine, nervous, and gastroenteric systems. They can regulate the expression of multiple genes and proteins involved in starvation–satiety processes, activate the brown adipose tissue, decrease lipogenesis and inflammation, increase lipolysis, and improve insulin sensitivity. This review provides a comprehensive view of nature-based therapeutic options to address the increasing prevalence of obesity. It offers a valuable perspective for future research and subsequent clinical practice, addressing everything from the molecular, genetic, and physiological bases to the clinical study of bioactive compounds.
The cyclodextrin researchers know well that the bioactive molecules listed above often suffer from low solubility and inappropriate stability. A large number of studies proved the beneficial effect of CD-based formulations.
Hidalgo-Lozada, G.M.; Villarruel-López, A.; Nuño, K.; García-García, A.; Sánchez-Nuño, Y.A.; Ramos-García, C.O. Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment. Int. J. Mol. Sci. 2024, 25, 2671. https://doi.org/10.3390/ijms25052671
One comment